Nobilis Health Corp. Appoints New Vice President of Marketing

June 08, 2017

HOUSTON, June 8, 2017 /PRNewswire/ -- Nobilis Health Corp. (NYSE MKT: HLTH) ("Nobilis" or the "Company") announced today the appointment of Phil Ayres as Vice President of Marketing. Mr. Ayres' primary responsibility will be managing and further developing the Company's direct-to-consumer (DTC) platform used to market the Company's nine nationally branded surgical procedures.

Nobilis Health Corp.

Mr. Ayres most recently served as the Director of Marketing for Travelocity, where he successfully developed a digital-based marketing strategy focused on maximizing performance through audience retargeting and digital platform customization. During his tenure, Mr. Ayres led Travelocity's search engine optimization (SEO) channel through a period of exponential growth while completely redesigning the company's display, retargeting and social direct response efforts, with a rigorous focus on vendor expansion and channel conversion optimization. These efforts resulted in improved performance across the Marketing Division, while saving the company tens of millions annually in reduced marketing spend.

Prior to his role at Travelocity, Mr. Ayres was the Director of Online Marketing at where he oversaw digital marketing operations in North America and led his team to numerous awards and nominations, including Advertiser of the Year, Innovator of the Year and's Gold Star Award, which the company reserves for the top 1% of its performers.

"As our marketing platform becomes more technology driven, Phil's addition to our team allows us to capitalize on his experience and improve our marketing platform. We believe the experience Phil possesses in designing and implementing digital-based marketing campaigns on a global level makes him tailor-made for this very important role," said Kenneth Efird, President of Nobilis. "Throughout the course of his career, Mr. Ayres has shown the ability to improve marketing operational efficiency through dedicated application of specific SEO tactics and network analytics. As Nobilis continues to scale its marketing programs, Mr. Ayres' leadership and proven ability to reduce customer acquisition cost through technology will impact the Company's performance."   

About Nobilis Health Corp.

Nobilis ( is a full-service healthcare development and management company, with 25 locations across Texas and Arizona, including 4 hospitals, 10 ASCs and 11 clinics. In addition, Nobilis partners with an additional 38 facilities across the country. Marketing nine independent brands, Nobilis deploys a unique patient acquisition strategy driven by proprietary direct-to-consumer marketing technology, focusing on a specified set of procedures that are performed at our centers by local physicians.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Canadian and United States securities laws, including the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and may be identified by the use of words such as "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan" or "continue." These forward-looking statements are based on current plans and expectations and are subject to a number of risks, uncertainties and other factors which could significantly affect current plans and expectations and our future financial condition and results. These factors, which could cause actual results, performance and achievements to differ materially from those anticipated, include, but are not limited to our ability to successfully maintain effective internal controls over financial reporting; our ability to implement our business strategy, manage the growth in our business, and integrate acquired businesses; the risk of litigation and investigations, and liability claims for damages and other expenses not covered by insurance; the risk that payments from third-party payers, including government healthcare programs, may decrease or not increase as costs increase; adverse developments affecting the medical practices of our physician limited partners; our ability to maintain favorable relations with our physician limited partners; our ability to grow revenues by increasing case and procedure volume while maintaining profitability at the Nobilis facilities; failure to timely or accurately bill for services; our ability to compete for physician partners, patients and strategic relationships; the risk of changes in patient volume and patient mix; the risk that laws and regulations that regulate payments for medical services made by government healthcare programs could cause our revenues to decrease; the risk that contracts are cancelled or not renewed or that we are not able to enter into additional contracts under terms that are acceptable to us; and the risk of potential decreases in our reimbursement rates. The foregoing are significant factors we think could cause our actual results to differ materially from expected results. However, there could be additional factors besides those listed herein that also could affect us in an adverse manner.

We have not undertaken any obligation to publicly update or revise any forward-looking statements. All of our forward-looking statements speak only as of the date of the document in which they are made or, if a date is specified, as of such date. Subject to a mandatory requirements of applicable law, we disclaim any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in our expectations or any changes in events, conditions, circumstances or information on which the forward-looking statement is based. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing factors and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016, filed on March 14, 2017, as updated by other filings with the Securities and Exchange Commission.

Contact Information:

Tuan Tran
Vice President, Investor Relations
(281) 925-0950


To view the original version on PR Newswire, visit:

SOURCE Nobilis Health Corp.